Ryder, J R
Gross, A C
Fox, C K
Kaizer, A M
Rudser, K D
Jenkins, T M
Ratcliff, M B
Kelly, A S
Kirk, S
Siegel, R M
Inge, T H
Article History
Received: 21 February 2017
Revised: 17 July 2017
Accepted: 2 August 2017
First Online: 14 August 2017
Competing interests
: Dr Inge received research grant funding from Ethicon Endosurgery for this project. Dr Kelly serves as a consultant for Novo Nordisk, Orexigen and Vivus Pharmaceuticals but does not accept personal or professional income for these activities. Dr Kelly receives research support in the form of drug/placebo from Astra Zeneca Pharmaceuticals. Dr Fox serves as a site principal investigator for a clinical trial sponsored by Novo Nordisk Pharmaceuticals. The remaining authors declare no conflicts of interest. No honorarium, grant or other form of payment was given to anyone to produce the manuscript.